BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 10727406)

  • 21. Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity.
    Visconti R; Gadina M; Chiariello M; Chen EH; Stancato LF; Gutkind JS; O'Shea JJ
    Blood; 2000 Sep; 96(5):1844-52. PubMed ID: 10961885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
    Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
    J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.
    Lejeune D; Dumoutier L; Constantinescu S; Kruijer W; Schuringa JJ; Renauld JC
    J Biol Chem; 2002 Sep; 277(37):33676-82. PubMed ID: 12087100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
    Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
    Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE).
    Schuringa JJ; Timmer H; Luttickhuizen D; Vellenga E; Kruijer W
    Cytokine; 2001 Apr; 14(2):78-87. PubMed ID: 11356008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes.
    Kayali AG; Austin DA; Webster NJ
    Diabetes; 2000 Nov; 49(11):1783-93. PubMed ID: 11078444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3.
    Udayakumar TS; Stratton MS; Nagle RB; Bowden GT
    Neoplasia; 2002; 4(1):60-7. PubMed ID: 11922392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
    Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
    Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain.
    Ortega-Pérez I; Cano E; Were F; Villar M; Vázquez J; Redondo JM
    J Biol Chem; 2005 May; 280(21):20867-78. PubMed ID: 15743762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes.
    Liang Q; Wiese RJ; Bueno OF; Dai YS; Markham BE; Molkentin JD
    Mol Cell Biol; 2001 Nov; 21(21):7460-9. PubMed ID: 11585926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK.
    Sundarrajan M; Boyle DL; Chabaud-Riou M; Hammaker D; Firestein GS
    Arthritis Rheum; 2003 Sep; 48(9):2450-60. PubMed ID: 13130464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of p38 MAP kinase increases okadaic acid mediated AP-1 expression and DNA binding but has no effect on TRE dependent transcription.
    Rosenberger SF; Gupta A; Bowden GT
    Oncogene; 1999 Jun; 18(24):3626-32. PubMed ID: 10380884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal transducer and activator of transcription 3 activation by the delta-opioid receptor via Galpha14 involves multiple intermediates.
    Lo RK; Wong YH
    Mol Pharmacol; 2004 Jun; 65(6):1427-39. PubMed ID: 15155836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription.
    Bode JG; Ludwig S; Freitas CA; Schaper F; Ruhl M; Melmed S; Heinrich PC; Häussinger D
    Biol Chem; 2001 Oct; 382(10):1447-53. PubMed ID: 11727828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3 regulates Nemo-like kinase by mediating its interaction with IL-6-stimulated TGFbeta-activated kinase 1 for STAT3 Ser-727 phosphorylation.
    Kojima H; Sasaki T; Ishitani T; Iemura S; Zhao H; Kaneko S; Kunimoto H; Natsume T; Matsumoto K; Nakajima K
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4524-9. PubMed ID: 15764709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rac is activated by tumor necrosis factor alpha and is involved in activation of Erk.
    Nosaka Y; Arai A; Kanda E; Akasaki T; Sumimoto H; Miyasaka N; Miura O
    Biochem Biophys Res Commun; 2001 Jul; 285(3):675-9. PubMed ID: 11453646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of STAT1 phosphorylation modulated by MAPKs, MEK1 and MSK1.
    Zhang Y; Cho YY; Petersen BL; Zhu F; Dong Z
    Carcinogenesis; 2004 Jul; 25(7):1165-75. PubMed ID: 14963018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells.
    Veit C; Genze F; Menke A; Hoeffert S; Gress TM; Gierschik P; Giehl K
    Cancer Res; 2004 Aug; 64(15):5291-300. PubMed ID: 15289335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.